Chloroquine-induced pruritus among patients with malaria.
A questionnaire survey was performed among 550 acutely febrile patients with malaria to determine whether pruritus accompanied chloroquine therapy when the drug was employed to suppress paroxysmal febrile attacks. Eighty-one (74.3%) of the 109 respondents, including two Asian and one white patients, recalled the past occurrence of regular (60%) or occasional (40%) pruritus under those conditions, and 15 black patients (13.8%) under active treatment were currently experiencing itching. The typical pruritic reaction following chloroquine administration was generalized, began after a latency of 11 +/- 9 hours (mean +/- SD of 15 acute reactions), increased to a moderately severe peak of intensity within 25 +/- 12 hours, remained maximal for about 12 hours, and then gradually subsided completely 55 +/- 21 hours after onset. Antihistamines were largely ineffective for the relief of pruritus. These results suggest that certain undetermined factors, present in febrile patients with malaria, predispose to 4-aminoquinoline-induced pruritus. Black patients may have an increased susceptibility to this symptomatic drug reaction.
D000293:Adolescent; D000328:Adult; D044383:Black People; D002648:Child; D002738:Chloroquine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D009549:Nigeria; D011537:Pruritus / Q000139:chemically induced*
D002738:Chloroquine